Navigation Links
Study shows 1 in 25 deaths worldwide attributable to alcohol
Date:6/26/2009

(Toronto) Research from Canada's own Centre for Addiction and Mental Health (CAMH) featured in this week's edition of the Lancet shows that worldwide, 1 in 25 deaths are directly attributable to alcohol consumption. This rise since 2000 is mainly due to increases in the number of women drinking.

CAMH's Dr Jrgen Rehm and his colleagues found that alcohol-attributable disorders are among the most disabling disease categories within the global burden of disease, especially for men. And in contrast to other traditional risk factors for disease, the burden attributable to alcohol lies more with younger people than with the older population.

Dr. Rehm still takes an optimistic 'glass half full' response to this large and increasing alcohol-attributable burden. "Today, we know more than ever about which strategies can effectively and cost-effectively control alcohol-related harms," Dr. Rehm said today. "Provided that our public policy makers act on these practical strategies expeditiously, we could see an enormous impact in reducing damage."

The study showed that Europe had a high proportion of deaths related to alcohol, with 1 in 10 deaths directly attributable (up to 15% in the former Soviet Union). Average alcohol consumption in Europe in the adult population is somewhat higher than in North America: 13 standard drinks per person per week (1 standard drink = 13.6 grams of pure ethanol and corresponds to a can of beer, one glass or wine and one shot of spirits) compared to North America's 10 to 11 standard drinks. The recent Canadian consumption rate is equivalent of almost 9 standard drinks per person per week age 15 plus, and has been going up, as has high risk drinking. Globally, the average is around 7 standard drinks per person per week (despite the fact that most of the adult population worldwide actually abstains from drinking alcohol).

Most of the deaths caused by alcohol were through injuries, cancer, cardiovascular disease, and liver cirrhosis.

"Globally, the effect of alcohol on burden of disease is about the same size as that of smoking in 2000, but it is relatively greatest in emerging economies. Global consumption is increasing, especially in the most populous countries of India and China."

CAMH is known for its pioneering research in the most effective ways of reducing the burden of alcohol. For example, CAMH endorsed the legislative change implemented this year requiring young Ontario drivers to maintain a 0% blood alcohol content; in many jurisdictions this measure has reduced alcohol-related crashes and saved lives.

Other evidence-based policies proven to reduce harms include better controls on access to alcohol through pricing interventions and outlet density restrictions as well as more focused strategies such as violence reduction programs in licensed premises. Within health care, provision of screening and brief interventions for high risk drinkers has enormous potential to reduce the contribution of alcohol to the onset of cancer and other chronic diseases.

"There are significant social, health and economic problems caused by alcohol," said Gail Czukar, CAMH's executive vice-president, Policy, Education and Health Promotion. "But research gives us sound, proven interventions that governments and health providers can use to address these problems."


'/>"/>

Contact: Kirk LeMessurier
kirk_lemessurier@camh.net
416-595-6015
Centre for Addiction and Mental Health
Source:Eurekalert

Related medicine news :

1. Veterans Affairs Researchers Study Benefits of Robot for Ankle Rehabilitation
2. U-M study finds voice box can be preserved, even with the largest cancers
3. Clinical Study Data Indicates that Celliant Reduces Pain
4. Girls Overall Self-Worth Improves With Contact Lens Wear, Study Shows
5. New Study Shows that Prebiotics, as Used by Jackson GI Medical, Increases Lifespan by 33%
6. Acclarent, Inc. Completes Office-Based Study Using Balloon Sinuplasty(TM) Technology
7. Study pinpoints novel cancer gene and biomarker
8. Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health
9. Study Finds Skin Cancer Rates Higher Among Athletes
10. Underweight and extremely obese die earlier than people of normal weight, study finds
11. Underweight and Extremely Obese Die Earlier Than People of Normal Weight, Study Finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 23, 2017 , ... The TouchPoint Solution, ... who entered metrics into the product’s app. The data replicates and validates ... that within just 30 seconds of using Buzzies, people experienced a 74 percent ...
(Date:1/24/2017)... Michigan (PRWEB) , ... January 24, 2017 , ... The ... other advocates for drug and alcohol awareness, have worked with communities to designate the ... year, observed January 23-29, 2017, the theme is “Shatter the Myths.” As a ...
(Date:1/23/2017)... ... January 23, 2017 , ... ... localization services for life science companies, has achieved ISO 17100:2015 certification following ... America. ISO 17100 is the globally recognized standard that establishes guidance for ...
(Date:1/23/2017)... ... 23, 2017 , ... The iaedp Foundation, recognized for its ... who treat the full spectrum of eating disorder problems, proudly announces the addition ... of the leading eating disorder treatments centers located throughout the U.S. As partners ...
(Date:1/23/2017)... ... 2017 , ... Sharon Kleyne, America’s leading water researcher, advocate and feared enemy ... of making new water infrastructure a number one priority. “As we usher in a ... infrastructure to become a top priority of our new political change agents.” Kleyne pointed ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... 23, 2017 ArisGlobal, a leading ... announces agClinical 3.3, the latest version of its comprehensive ... science organizations to confidently and efficiently meet new compliance ... the electronic trial master file so that compliance is ... ...
(Date:1/23/2017)... 2017  HOPE BIOSCIENCES announced today that it ... commercialize nuc -gemcitabine™ (APTA-12/HOPE-888) through a licensing ... nuc -Gemcitabine consists of Antisoma,s ... found on many cancer cells, and dFdCMP, an ... conjugates) or SMDCs (small molecule drug conjugates), which ...
(Date:1/23/2017)... 23, 2017  Therabron Therapeutics, Inc., a clinical-stage ... in respiratory care, today announced that the European ... has granted Orphan Drug Designation for Therabron,s CG367 ... Syndrome (BOS).  "We are pleased to ... to treat patients diagnosed with BOS following lung ...
Breaking Medicine Technology: